Podcasts about hussain

The Indian-born tabla player and composer, teacher, and advocate Zakir Hussain, son of Ustad Alla Rahka, who passed away in late 2024, wasn't just a virtuoso improviser - he was one of the world's exceptional percussionists, working in many genres, and was the world's preeminent tabla master. He was a great communicator in many musical languages, including jazz, Afro-Cuban rhythms, Nigerian talking drums, or Indonesian gamelan; he was also a great listener and a bringer of joy (editor can't help herself.) One of the most exciting ways that Zakir Hussain shared tabla specifically, and percussion more broadly was by way of the Masters of Percussion Tour – which was exactly as stunning and marvelous as a music fan (especially a drum nerd) might ever imagine. Zakir turned the tabla into a global instrument by way of his incredible collaborations, playing with everyone from George Harrison to Mickey Hart of the Grateful Dead, from John McLaughlin's Shakti and Yo Yo Ma's Silk Road Project; he's laid down beats for Scottish fiddlers Charlie McKerron (Capercaillie) and Patsy Reid (formerly of Breabach); played concertos with western orchestras, with and without banjo player Bela Fleck and bassist Edgar Meyer, and performed and recorded with scores of Indian classical musicians. Zakir Hussain enjoyed the different challenges that each new collaborator “will throw at him”. For this edition of the Soundcheck Podcast, Ustad Zakir Hussain joined Pandit Rahul Sharma, the son of illustrious santoor master Pandit Shivkumar Sharma, who established the pedigree of the santoor within Indian Classical Music. Pt. Rahul Sharma has since built on his father's style, “taking the santoor to new corners of the world”, (Darbar.org). Rahul Sharma has also collaborated widely across genres, having released some 60 albums, split between classical Indian music and more experimental recordings. Rahul Sharma and Zakir Hussain played in-studio in Oct of 2024, just about six weeks before Hussain passed away. - Caryn Havlik Set list: 1. Dhun: Misra Pahadi 2. Dhun Keharwa Sharma explains the roots of the santoor, and gives a quick demonstration of its 94 strings which require precise tuning:  Zakir Hussain also gave an intimidatingly fast explainer of some of the syllables of tabla, what the left and right hand might do, with unbelievable and impressive speed: See their performances:    

Hussain Rehman a native of Chicago's western suburbs grew up in Villa Park IL. Hussain has been an avid competitive shooting athlete for nearly a decade as well as an advocate for gun ownership in the Muslim community. This advocacy led to the founding of Qawwam Tactical, a firearms training academy teaching basic and advanced tactics integrated with the Quranic concepts of Qawwamun and Qiwamah. Links: website: https://www.qawwamtactical.com insta: @qawwam.tactical fb: https://www.facebook.com/profile.php?id=61552598545763 www.qawwamtactical.com PLEASE SUPPORT THE MAD MAMLUKS: Please support us on https://Patreon.com/themadmamluks You can also support us on PayPal https://themadmamluks.com/donate VISIT OUR SOCIALS FOR MORE DISCUSSIONS: Twitter https://twitter.com/TheMadMamluks Instagram https://www.instagram.com/themadmamluks/ Tiktok https://www.tiktok.com/@themadmamluks SIM: https://x.com/ImranMuneerTMM  MORT: https://www.tiktok.com/@morttmm Harry: https://x.com/MrHarry198 Twitter: ----------- #palestine #palestineisrael #gaza #genocide #themadmamluks #podcast #honesty #oppression #israel #oud #syria #syriancivilwar

Dars E Tirmizi #66 - Mufti Hussain Khalil Khail｜Mufti Tariq Masood Speeches

Dars E Tirmizi #65 - Mufti Hussain Khalil Khail｜Mufti Tariq Masood Speeches

Dars E Tirmizi #64 - Mufti Hussain Khalil Khail｜Mufti Tariq Masood Speeches

Once upon a time, All India Radio's Urdu service used to broadcast film stories. Here is the story of the film Shankar Hussain, briefly written and narrated by Anwaar Ahmed, a famous radio announcer from that era.Shankar Hussain (A 1977 Film in Hindi)Dr Uday Shankar is a kind-hearted Hindu gentleman who has chosen to practice medicine in a village rather than make money by working in a large city. Once, a devastating flood hits a nearby village and he goes there to minister to the affected people. At this time, he happens to rescue a Muslim child, Husain, whose entire family has been wiped out. He raises the boy as his own, alongside his own son, Ajay. As a good Hindu, he decides to raise the boy in the religion of his own parents, and Husain thus grows up to be a practising Muslim living in the backdrop of a Hindu household. Everyone loves the new addition to the household and Husain also is deeply attached to his new family.Yusuf NaqviDirectorKamal AmrohiWriterCurated and Cover by Irfan

durée : 00:23:03 - Chrétiens d'Orient - par : Sébastien de Courtois - Fawaz Hussain et Tigrane Yegavian évoquent la figure magistrale de Sayat-Nova, un troubadour et poète arménien du XVIIIe siècle. - réalisation : François Caunac - invités : Fawaz Hussain Romancier; Tigrane Yegavian Professeur de relations internationales à l'Institut Schiller, membre du comité de rédaction de la revue Conflit.

Send Crystal a text letting her know what you thought about the show!Welcome to another episode of the EarthX Conference series!When you think of ocean conservation, coral reefs likely come to mind. But what if the real unsung hero of the sea is something far less glamorous—and far more vital? Filmmaker Adam Hussain brings us into the underwater world of kelp forests in his upcoming documentary Seaforestation. These underwater ecosystems cover more area than coral reefs, support an astonishing range of marine life, and play a quiet but powerful role in fighting climate change.Adam shares surprising facts—like how kelp forests could be worth more than the Great Barrier Reef in economic value—and tells stories from the field, including sea lions hopping aboard boats and witnessing the last 5% of Tasmania's once-vast giant kelp forests. If you've ever dismissed seaweed as just ocean salad, this episode might just change your mind.Highlights:Why kelp is critical to coastal ecosystems and climate stability?What's threatening these forests—and it's not just one thing?How scientists are using “assisted adaptation” to help kelp survive warming oceans? What YOU Can DoMost people don't even know kelp forests exist, let alone how important they are. Just talking about what you learned in this episode can spark awareness and curiosity.Companies that farm seaweed responsibly (rather than harvesting it from the wild) are helping create demand for sustainable ocean industries. Look for packaging and food products made from farmed seaweed.Ocean warming is one of the biggest threats to kelp. Cutting back on emissions—from energy use to transportation to food choices—can make a difference at scale. ResourcesSeaforestation movie. https://seaforestfilm.com/Want a free guide to help you become a force for nature? Get it HERE!If you enjoyed this episode, be sure to subscribe, rate, and review it! This helps to boost its visibility. Hit me up on Instagram and Facebook and let me know what actions you have been taking. Adopting just one habit can be a game-changer because imagine if a billion people also adopted that! What difference for the world are you going to make today?

This is the Catchup on 3 Things by The Indian Express and I'm Ichha SharmaToday is the 2th of March and here are the headlines.Kunal Kamra, in a standup show, had taken a jibe at Deputy Chief Minister and Shiv Sena chief Eknath Shinde referring to him as a “gaddar” (traitor) following which an FIR for defamation was registered against the comedian on Monday. Shiv Sena workers had vandalised the Habitat studio where the standup show was shot, with 12 of them being arrested and later released on bail. Maharashtra Legislative Council Chairman Ram Shinde on Thursday said that the breach of privilege motion filed against stand-up comedian Kunal Kamra has been accepted and sent to the privilege committee of the legislative council.The Assam police arrested journalist Dilwar Hussain Mozumdar on Tuesday night after detaining him for several hours following his coverage of a protest against the Assam Co-operative Apex Bank (ACAB). Hussain is a reporter with the Assam-based digital media portal The CrossCurrent, known for its investigative reportage on the state government. He is also the assistant general secretary of the Guwahati Press Club. The grounds for his arrest, which were presented to his family hours after he was detained, state that he was arrested for alleged criminal intimidation and violation of provisions of the Scheduled Castes and Scheduled Tribes (Prevention of Atrocities) Act for “offensive remarks” against the complainant.Telangana Chief Minister A Revanth Reddy moved a resolution against delimitation in the legislative assembly on Thursday. The resolution read, quote “The house expresses its deep concern on the manner in which the impending delimitation exercise is being planned, without transparent consultations with stakeholders.” unquote. The resolution was later adopted by the House and passed. Reddy posted about it on X stating:quote “…People of Telangana and citizens of all other states of south India are united in protecting our rights” unquote.US President Donald Trump has decided to expand his trade war to the world's most traded product — automobiles and auto parts — by announcing 25 per cent tariffs on them from April 3. This has raised the uncertainty over Indian exports of auto components worth nearly $7 billion to the US and their future growth potential in the North American market. Citing national security concerns, the White House said that automobiles would be subject to 25 per cent tariffs starting on April 3 — a day after US reciprocal tariffs are set to come into effect — while auto parts would face similar tariffs “no later than May 3 2025,” unless such actions are expressly “reduced, modified, or terminated.”South Korea's government has been held responsible for multiple human rights violations for fabricating birth records, falsely reporting that children had been abandoned over decades for a programme which sent about 200,000 children and babies abroad for adoption, a landmark enquiry by the truth commission has found. Private agencies were able to export babies and children due to government's lack of oversight and the agencies were driven by profit which enabled the “mass exportation of children” and numerous examples of coercion, false records and fraud have been found in the scheme.This was the Catch Up on 3 Things by the Indian Express.

#SYRIA: SHARAA GRABS FOR POWER., HUSSAIN ABDUL-HUSSAN FDD 1888 DAMASCUS

Mohammed Hussain, a Mumbai-based stand-up comedian and writer, is celebrated for his engaging storytelling and observational humor, delivered in Hindi with a blend of anecdotal and dark comedy. Born in Karnataka to a Gujarati family, Hussain has been a staple in India’s comedy circuit since 2017, collaborating with giants like Netflix, Amazon Prime, and Hotstar on sketches, live shows, and promotional campaigns. His YouTube channel, Officiallysane, showcases his stand-up performances, including viral bits like his humorous take on trekking to Everest Base Camp. In 2023, Hussain launched his solo show Shaadi Shud I?, a witty exploration of marriage and relationships inspired by his own journey—engaged at 19 and married at 25 after a nine-year relationship. Expanding his creative range, he joined comedians Mohammed Anas and Vineeth Srinivasan in September 2024 for Reel-ing It In!, a live sketch and parody experiment. Beyond comedy, Hussain’s three-year stints as Zee Entertainment’s Assistant Sales Manager and a scriptwriter at Insider.in highlight his versatility. In a candid 2021 interview with National Herald, he voiced concerns over India’s socio-political climate impacting artistic freedom, even contemplating a move to Canada. Addressing fan queries, Hussain humorously tackles topics like Ramzan’s patience paradox, intra-community dynamics (referencing unedited YouTube cuts), potential collaborations with his wife beyond reels, and modern arranged marriage advice—playfully nodding to peer Mohammed Anas’ role as a “Vijaykar” (matchmaker). With sharp wit and relatable narratives, Hussain continues to push boundaries, making him a must-watch in India’s evolving comedy landscape. Explore his work for laughs, insights, and a fresh take on life’s absurdities!See omnystudio.com/listener for privacy information.

This is the Catchup on 3 Things by The Indian Express and I'm Ichha SharmaToday is the 26th of March and here are the headlines.In a late-night order on Tuesday, former Enforcement Directorate chief Sanjay Kumar Mishra was appointed a full-time member of the Economic Advisory Council to the Prime Minister (EAC-PM). The EAC-PM, an independent advisory body, has had one vacancy since the death of its former chairman Bibek Debroy in November 2024. The former Ed chief had a high-profile stint, and somewhat ignominious end, as the ED Director. After he took over in 2018, the agency went about pursuing money laundering investigations at a break neck pace. By 2022, 65% of all asset attachments carried out by the ED in the previous 17 years had been made under his signature, with the agency carrying out more than 2,000 raids.The Assam police arrested journalist Dilwar Hussain Mozumdar last night after detaining him for several hours following his coverage of a protest against the Assam Co-operative Apex Bank (ACAB). Hussain is a reporter with the Assam-based digital media portal The CrossCurrent, known for its investigative reportage on the state government. He is also the assistant general secretary of the Guwahati Press Club. The grounds for his arrest, which were presented to his family hours after he was detained, state that he was arrested for alleged criminal intimidation and violation of provisions of the Scheduled Castes and Scheduled Tribes (Prevention of Atrocities) Act for “offensive remarks” against the complainant.A spate of chain-snatching incidents in Chennai, executed within an hour on yesterday culminated in the fatal police shooting of one of the suspects near Taramani railway station today. Police said the men, part of a notorious gang, targeted elderly women and morning walkers in neighbourhoods along East Coast Road, Adyar and Besant Nagar. According to the police, two suspects, both from Uttar Pradesh, were intercepted at Chennai International Airport as they attempted to board a flight to New Delhi.A day after what Donald Trump termed as “the only glitch in two months”, US National Security Adviser, Mike Waltz, said he took full responsibility for leak of military plans in a Signal chat. He said quote, “I take full responsibility. I built the group. My job is to make sure everything is coordinated,” unquote in an interview with Fox News, in which he conceded: “it's embarrassing”. Waltz's comments came a day after Jeffrey Goldberg, editor-in-chief of the Atlantic, revealed that he was added to a group on Signal, a private messaging app, that included vice-president JD Vance, defense secretary Pete Hegseth, secretary of state Marco Rubio and other high-profile figures discussing “operational details” of US airstrikes on Houthis in Yemen.South Korea's government has been held responsible for multiple human rights violations for fabricating birth records, falsely reporting that children had been abandoned over decades for a programme which sent about 200,000 children and babies abroad for adoption, a landmark enquiry by the truth commission has found. Private agencies were able to export babies and children due to government's lack of oversight and the agencies were driven by profit which enabled the “mass exportation of children” and numerous examples of coercion, false records and fraud have been found in the scheme.This was the Catch Up on 3 Things by the Indian Express.

Rosie O'Donnell decides to sit out the Trump years in Ireland, trashing the U.S. press corps as she runs off to safety. Ben riffs. Rummana Hussain talks about cuts at the Sun-Times. And the desperate state of journalism. A few words about Bill Maher, once Mr. Politically Incorrect, crying like a snowflake cause he thinks Saturday Night Live was mean to MAGA. Boo hoo, hoo, Billy. Also, what's with Rummana's hat? Has she gone MAGA? Look again. Rummana is an columnist for the Chicago Sun-Times. Her views are her own. See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

Hosted on Acast. See acast.com/privacy for more information.

Dars E Tirmizi #62 - Mufti Hussain Khalil Khail｜Mufti Tariq Masood Speeches

Today, on the 168th episode of the As The Raven Dreams podcast, we have 12 True Chilling stories. These stories come from the shadowy corners of reality, where everyday life takes an eerie twist & ordinary people experience the extraordinary. Today we will be diving into some Creepy Neighbor stories as well as some chilling Paranormal stories. If you enjoyed this episode, be sure to like or rate the podcast, and leave me a comment with your thoughts if the platform your own supports it! Scary story episodes 2 to 3 times a week (New stories On Wed/Fri, Comps/remasters on Sundays) If you have a story to submit, would like to find where to listen to the podcast, or want to find me on social media platforms, all of that info can be found at https://www.astheravendreams.com You can also send stories into my subreddit (r/theravensdream) or email them to me at AsTheRavenDreams@gmail.com Want to check out some ATRD Podcast Merch? ➤ https://teechip.com/stores/astheravendreams Or for signed merch ➤ https://ko-fi.com/AsTheRavenDreams I wrote a novel, "The Insomniac's Experiment" by Raven Adams! Check it out on amazon (Or you can email me for a signed copy!) Join Patreon to get early access and support the Podcast! ➤ https://www.patreon.com/AsTheRavenDreams Check out my gaming channel with my pal Ghost_Ink ➤ @superNefariousBros On YouTube Disclaimer ➤ Episodes include a content warning for language and sensitive/disturbing content. Listener discretion is always advised. ALL Audio and visuals on this podcast are copyright of AS THE RAVEN DREAMS / RAVEN ADAMS and may not be duplicated, in any format. Bless This Mess. #AsTheRavenDreams #TrueScaryStories #GlitchInTheMatrix Thank you to all of the authors that have stories in todays episode... Scott, D. C. Pool, Anne, Vanessa, Hussain al rashid, Eryn k, Vanessa77, Brylee white, ClosedForBusiness, Joy, NewOrleansLifer, Kookaburra-babe... As Well As Any Author That Has Requested Anonymity. TimeStamps… 1 ➤ 00:24 2 ➤ 10:59 3 ➤ 14:58 4 ➤ 20:11 5 ➤ 26:54 6 ➤ 35:03 7 ➤ 39:11 8 ➤ 50:52 9 ➤ 53:31 10 ➤ 55:42 11 ➤ 1:01:06 12 ➤ 1:03:07 Midrolls after the first story and at about 53 Minutes ----- #TrueScaryStories #AsTheRavenDreams #GlitchInTheMatrix #RedditStories And Remember; You are loved, you are important, and you are valid. Never let anyone tell you otherwise. Learn more about your ad choices. Visit megaphone.fm/adchoices

Dars E Tirmizi #61 - Mufti Hussain Khalil Khail｜Mufti Tariq Masood Speeches Hosted on Acast. See acast.com/privacy for more information.

Journalist, Columnist and President of AIK News, Fahd Hussain, comes on The Pakistan ExperienceToday on TPE we discuss, what is wrong with journalism in Pakistan, social media, 26th November, Dawn Leaks, Hamid Mir getting shot, Fahd Hussain taking a Government position, Shahbaz Sharif's philosophy, Maryam Nawaz and political communication.Fahd Husain is a renowned news media professional with over 25 years of experience in journalism.The Pakistan Experience is an independently produced podcast looking to tell stories about Pakistan through conversations. Please consider supporting us on Patreon:https://www.patreon.com/thepakistanexperienceTo support the channel:Jazzcash/Easypaisa - 0325 -2982912Patreon.com/thepakistanexperienceAnd Please stay in touch:https://twitter.com/ThePakistanExp1https://www.facebook.com/thepakistanexperiencehttps://instagram.com/thepakistanexpeperienceThe podcast is hosted by comedian and writer, Shehzad Ghias Shaikh. Shehzad is a Fulbright scholar with a Masters in Theatre from Brooklyn College. He is also one of the foremost Stand-up comedians in Pakistan and frequently writes for numerous publications. Instagram.com/shehzadghiasshaikhFacebook.com/Shehzadghias/Twitter.com/shehzad89Join this channel to get access to perks:https://www.youtube.com/channel/UC44l9XMwecN5nSgIF2Dvivg/joinChapters:0:00 Introduction1:25 What is wrong with Journalism in Pakistan2:45 Have the big players co-opted Social Media?10:00 News, Information Gathering and Reporting13:40 News Models in Pakistan16:30 Struggles of doing Journalism in Pakistan24:30 Journalist Training and what makes a good Journalist27:00 26th November and wanting to believe in News to be true37:35 DAWN Leaks40:23 Hamid Mir getting shot44:30 Fahd Hussain taking a position with PML-N52:55 2013 PTI was different58:30 Shahbaz Sharif's philosophy and current Hybrid regime1:12:58 2018 mai bhi aisa hua tha and what is happening today1:17:54 Fahd Hussain's role in the Government1:19:19 Maryam Nawaz and PML-N1:26:05 Imran Khan and political communication1:29:59 AIK News and Private Corporate ownership of Channels1:36:00 How much do owners intervene1:38:58 Audience Questions

Dars E Tirmizi #60 - Mufti Hussain Khalil Khail｜Mufti Tariq Masood Speeches

LEBANON, ISRAEL, AND THE GULFHEADLINE 1: The IDF carried out a strike in Damascus yesterday.HEADLINE 2: Qatar is preparing to supply natural gas to Syria.HEADLINE 3: The United Nations published a report accusing Israel of perpetrating “genocidal acts” in Gaza.--FDD Executive Director Jon Schanzer provides timely situational updates and analysis, followed by a conversation with Hussain Abdul-Hussain, a research fellow at FDD.Learn more at: https://fdd.org/fddmorningbrief

Dars E Tirmizi #59 - Mufti Hussain Khalil Khail｜Mufti Tariq Masood Speeches

Dars E Tirmizi #58 Mufti Hussain Khalil Khail｜Mufti Tariq Masood Speeches

Dars E Tirmizi #57 - Mufti Hussain Khalil Khail｜Mufti Tariq Masood Speeches

Dars E Tirmizi #56 - Mufti Hussain Khalil Khail Mufti Tariq Masood Speeches

IRAN: WHAT BASIS FOR TEHRAN'S SO-CALLED SHIA REGIME AND ITS CLAIMS ON JERUSALEM? HUSSAIN ABDUL-HUSSAIN 2925 PERSIA

Dars E Tirmizi #55 - Mufti Hussain Khalil Khail | Mufti Tariq Masood Speeches

Dars E Tirmizi #54 - Mufti Hussain Khalil Khail | Mufti Tariq Masood Speeches

Making the most of Ramadan - Mufti Hussain Kamani 100% of your donations today goes towards the means of providing accessible Islamic knowledge to people around the world: supportqalam.com. Like us on Facebook: facebook.com/qalaminstitute Follow us on Twitter: twitter.com/qalaminstitute Follow us on Instagram: instagram.com/qalaminstitute Subscribe on Youtube: youtube.com/user/qalaminstitute

Living in Pakistan – The Reality w/ Isa Hussain This episode is one I've been SO excited about! I sat down with Isa Hussain (@isa_unscripted), a UK-born, Pakistan-raised content creator who's shaking up the internet with his raw, hilarious, and eye-opening content about life in Pakistan. Isa's mission? To break the myths about Pakistan and show Western-born Pakistanis (and Muslims in general) that moving back "home" isn't just possible, it might actually be the best decision you ever make.  In this episode, we dive deep into: ✅ Isa's journey from the UK to Pakistan – how his dad saw the future and made a bold move 20 years ago ✅ The biggest myths about moving to Pakistan (Is it safe? What about WiFi? Can you actually live comfortably?) ✅ The REAL cost of living in Pakistan vs. the UK (this one will shock you) ✅ Why he believes Muslims in the West should consider making Hijra to Muslim countries ✅ How Isa's first-ever Instagram video went viral, launching his mission to change perceptions about Pakistan If you've ever thought about moving back to Pakistan – or just want to hear an inspiring story from someone who's making an impact – this one's for you! -- Get an Education degree from an accredited university by Muslims, from the comfort of your home: http://www.iou.edu.gm/fg

Hosted on Acast. See acast.com/privacy for more information.

Today's news: Pune bus rape accused Dattatraya Gade detained, say police, US judge halts Trump administration's calls for mass firings at agencies, Hussain, Atherton mocked over 'Dubai' claim in 2023 World Cup reminder, Hip hop legend Kevin Liles accused of sexual assault in the 2000s: New lawsuit

Third Coast Percussion is a Grammy-winning classical quartet based in Chicago. They're all composers themselves, but they've also worked with a wide variety of other composers, including Philip Glass and the late great tabla player Zakir Hussain. Their new EP, Murmurs In Time, features Zakir's work of that name, and he was supposed to join Third Coast Percussion here today, but as you may know, he passed away in December. This Soundcheck studio premiere of the work features a disciple of Hussain's, Salar Nader. We'll also hear an excerpt from another work written for Third Coast Percussion, by Tigran Hamasyan, the Armenian jazz pianist and composer. Oh – and it's in 23/8, for anyone counting along. (-John Schaefer) Set list: 1. Tigran Hamasyan – Sonata for Percussion, 3rd Mvmt. – “23 for TCP” 2. Zakir Hussain: Murmurs In Time – second mvmt.

In this episode of the PRS Global Open Keynotes podcast, Dr. Eric Wagner discusses the pros and cons of joint replacement and joint fusion for interphalangeal joint arthritis.   This episode discusses the following PRS Global Open article: “Utilization of Interphalangeal Joint Arthroplasty and Arthrodesis in the United States From 2010 to 2019” by Erica L. Smearman, Anthony L. Karzon, Hayden L. Cooke, Zaamin B. Hussain, Musab Gulzar, Nina Suh, Michael B. Gottschalk and Eric R. Wagner. Read it for free on PRSGlobalOpen.com: https://journals.lww.com/prsgo/fulltext/2025/01000/utilization_of_interphalangeal_joint_arthroplasty.54.aspx Dr. Eric Wagner is an Associate Professor in the Department of Orthopaedics at Emory University School of Medicine in Atlanta, Georgia. Your host, Dr. Damian Marucci, is a board-certified plastic surgeon and Associate Professor of Plastic Surgery at the University of Sydney in Australia. #PRSGlobalOpen; #KeynotesPodcast; #PlasticSurgery; Plastic and Reconstructive Surgery- Global Open

The Exchange is a drama series set in 1980s Kuwait, focusing on two women, Farida and Munira, who navigate the male-dominated world of the Kuwait Stock Exchange. The show delves into their professional and personal challenges as they strive to make their mark in the financial sector. The series has received positive reviews for its compelling storytelling and strong performances. The Exchange" Season 2, released on February 13, 2025, continues to follow Farida and Munira as they navigate the male-dominated world of the Kuwait Stock Exchange in the 1980s. The season delves deeper into their personal and professional challenges, highlighting their resilience and determination. You can watch "The Exchange" Season 2 on Netflix.#hikmatwehbipodcast #Netflix_TheExchange#TheExchange#Kuwaiti_Netflix_Series#Netflixmena#podcast#arabicpodcast#hikmatwehbipodcast #wstudiodxbحكمت_وهبي#حكمت_وهبي_بودكاست##مسلسل_نتفليكس#نتفليكس#

Trump says no judge tells me what to do. Ben riffs. Rummana Hussain ponders the day's great questions. Can Trump remove the Associated Press from the White House cause they won't bow to his commands? Can he disobey the rulings of federal judges? Can he command Palestinians to leave Gaza? Is that even a plan or just Trump trash talking? Is Trump more powerful than Mayor Daley was in Chicago? Aldo a few words about the AP style book. Rummana is an editorial writer and columnist for the Chicago Sun-Times. Her views are her own.See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

JCO PO author Dr. Hatim Husain at University of California San Diego, shares insights into his JCO PO article, “Adagrasib Treatment After Sotorasib-Related Hepatotoxicity in Patients With KRASG12C-Mutated Non–Small Cell Lung Cancer: A Case Series and Literature Review”, one of the top downloaded articles of 2024. Host Dr. Rafeh Naqash and Dr. Husain discuss how to utilize real-world and clinical trial data to discern the safety of adagrasib (another KRASG12C inhibitor), following sotorasib discontinuation due to hepatotoxicity. TRANSCRIPT Dr. Rafeh Naqash: Hello and welcome to JCO Precision Oncology Conversations where we bring you engaging conversations with authors of clinically relevant and highly significant JCOPO articles. I'm your host, Dr. Rafeh Naqash, Podcast Editor for JCO Precision Oncology and Assistant Professor at the OU Stephenson Cancer Center.  Today, I'm very excited to be joined by Dr. Hatim Hussain, Professor of Medicine at the University of California, San Diego, and author of the JCO Precision Oncology article, “Adagrasib Treatment After Sotorasib-Related Hepatotoxicity in Patients With KRAS-G12C-Mutated Non-Small Cell Lung Cancer: A Case Series and Literature Review.” This was one of the top downloaded articles of 2024. And the other interesting thing is we generally don't do podcasts for case reports or case series, so this is one of the very few that we have selected for the podcast.  And at the time of the recording, our guest disclosures will be linked in the transcript.  Dr. Hussain, welcome to our podcast and thank you for joining us today. Dr. Hatim Husain: Thank you Dr. Naqash. Such a pleasure to be here and to speak with you all. Dr. Rafeh Naqash: And for the sake of this podcast, we'll refer to each other using our first names. So again, as I mentioned earlier that this is one of the very few case reports that we have selected for podcasts in JCOPO and the intention was very deliberate because it caters to something that is emerging where we are trying to treat more KRAS mutant patients with different KRAS inhibitors. And you tried to address one very unique aspect of it in this article which pertains to toxicity, especially hepatotoxicity. So for the sake of our listeners who tend to be community oncologists, trainees, academic faculty, can you tell us what are KRAS inhibitors? What is KRAS-G12C? And how do some of these approved KRAS inhibitors try to inhibit KRAS-G12C? Dr. Hatim Husain: Sure. For a long time actually we've not had a selective way to inhibit mutant KRAS. And over the last several years actually now, we've seen some dramatic advances here, particularly with the FDA approval of some of the selective inhibitors against the G12C variant. So KRAS-G12C is an isoform of KRAS that is most common in lung cancer and in fact actually is a transversion mutation in the KRAS gene that is a product of the carcinogen of tobacco. And in fact, the incidence of KRAS-G12C in lung cancer, it's quite astounding where as many KRAS-G12C patients there are, there can be, as you know, more than EGFR patients in certain populations and cohorts. The medicines sotorasib and adagrasib were rationally designed to be selective KRAS-G12C inhibitors. And the way that they do this is that they lock the KRAS protein in the OFF state. KRAS is a protein that oscillates between an ON and an OFF state and by virtue of locking the protein in an OFF state, it has shown inhibition of downstream signaling and mitigation of tumor growth and, in fact, tumor cell death. Dr. Rafeh Naqash: I absolutely love the way you describe the ON and OFF state, the oscillation where the ON is bound to the GTP and the OFF is bound to the GDP. The two KRAS inhibitors as currently FDA approved, as you mentioned, are RAS OFF inhibitors and they're emerging KRAS inhibitors that are RAS ON. So now, as we have known from previous data related to immunotherapy and EGFR TKIs such as osimirtinib where toxicity tends to be a compounded effect when you have osimertinib given within a certain timeline of previous checkpoint therapy, we've seen that in the clinic as the data for these KRAS inhibitors is emerging, you talk about some very interesting aspects and data about what has been published so far with regards to prior use of immunotherapy or chemo immunotherapy and the subsequent use of KRAS inhibitors. Could you elaborate upon that? Dr. Hatim Husain: Sure. So for this population of patients, the first line approved strategy is a strategy that most cases will incorporate immune therapy and chemotherapy. Immune therapy can have some important responses for patients with KRAS-G12C. This may be due to the fact that KRAS-G12C patients may have a higher incidence of prior smoking, perhaps higher mutation burdens in some patients, and perhaps immunogenicity is defined in that context. So the standard of care in the first line currently includes immune therapy or immune therapy and chemotherapy. Where the current FDA approvals for selective G12C inhibitors are are after the first line of therapy. There are a number of trials exploring these medicines in the first line to see if they may be incorporated into a future treatment paradigm. Dr. Rafeh Naqash: Thank you for that explanation. Now, going to what you published in this manuscript, can you help us understand the context of why you looked at this? Even though the data just comprises a case series of a handful of patients, but the observations are very interesting and these are real world scenarios where we often tend to be in situations where an individual has had toxicity on a certain drug and may have some response to that drug, but at the same time, the toxicity is challenging. And then you try to debate whether another drug in the same class might be beneficial without those toxicities. So you've tried to address that to some extent using this data set. So can you elaborate upon the question, the methodology, what you tried to look at, and important observations that you have? Dr. Hatim Husain: Yes, our paper was actually inspired by one of my patients. My patient was a patient who had received chemotherapy and immune therapy and actually in the past, even, you know, additional lines of immune therapies, it was really coming to the edge of where standard treatments would exist. It was right at the same time that these selective inhibitors had been approved and the patient had received sotorasib. And what was remarkable was, when given sotorasib, patient had a very high peak and spike in the transaminases. And we would do different trials of strategies around dose, around interruptions. And it was becoming quite difficult, actually, for the patient to proceed with additional therapy. It was around similar times, actually, and I do want to make a note that the patient was progressing, driven in large fact by the fact that we've had to interrupt the medicine. So we feel and believe that the patient had had inadequate dosing because of the level of toxicity that the patient was having with transaminase increase. So it was around the same time that adagrasib was first commercially available that we were at that point, and we did a trial of adagrasib post-sotorasib, largely driven by necessity, without having additional options to provide this patient in our environment. What was remarkable was when the patient received the adagrasib, there were no spikes in transaminases similar to what we had seen before. And that really led us thinking and to say, “Is this adverse event of transaminase increase or hepatotoxicity, is this a class effect with KRAS-G12C inhibitors, or is it more nuanced than that? Are there different, perhaps, mechanisms by which the medicines may work that may more or less differentially contribute to this adverse event?” And so that inspired us to kind of do a larger analysis, kind of really reach out to a larger network of physicians to gather insights and to gather responses in patients who had had a serial approach of sotorasib and then adagrasib.  What we found in this process was, in fact, actually there were many more cases of patients who resembled my patient, where the sequence of sotorasib going to adagrasib may have demonstrated differential contribution of hepatotoxicity in that context. And that really motivated us to put the publication together to due diligence, and in the publication spend a lot of time to kind of outline each patient case in detail around metrics surrounding time from last immune therapy, the number of days on sotorasib, the best response to sotorasib, the interval between sotorasib and adagrasib, the duration of adagrasib and then the grade of hepatotoxicity seen in each of the contexts, and particularly kind of the adagrasib and patient disease status as well. We were quite inspired by the effort to try to, if we do not have randomized data in comparison of one medicine to another, which we do not at this juncture, we do not have a randomized analysis to really diligently and rigorously compare the rates of AEs across each medicine, and even in sequence, we do not have that with immune therapy. But what we felt was trying to get more analysis of this sequential approach of, if patients had received a medicine, had to be taken off because of toxicity and then actually tried on a new medicine, what were those rates? We felt like that was at least some information to try to get at this question. Dr. Rafeh Naqash: And you bring forward a very important point, which is, a lot of times in the real world setting we don't have cross trial comparisons that can be fully applicable, or we don't have trials that compare two drugs of the same class with respect to the AE profile or efficacy. And observations like the one that you described that led to this study are extremely critical in trying to help answer these questions.  From a data standpoint, and you allude to it to some extent in your manuscript, the trials that are trying to address combination of KRAS-G12C with immunotherapy, especially sotorasib or adagrasib, can you elaborate on that data, what has been published so far and summarize it for our listeners? Dr. Hatim Husain: So there is data from clinical trials looking at patients actually who have received concomitant immune therapy and sotorasib. What was seen in this, in a real world analysis, was that some patients actually who had received sotorasib within a close proximity of immune therapy, as well as a larger study actually which showed in combination there were higher rates of hepatotoxicity in that context. In fact, there were rates of grade 3 hepatotoxicity. And I think built upon that data there's a recognition in the field that we have to be very diligent in terms of even the clinical trial designs in how to understand the pairing between immune therapy and selective G12C inhibitors. There are many trials that are ongoing, one of the studies that is ongoing is known as the KRYSTAL-7 study, which is evaluating adagrasib in combination with pembrolizumab in the first line. And we await more information on that strategy as well. In the context of sotorasib, because of some of the trials that have shown higher rates of hepatotoxicity, there are some additional trials now looking at sotorasib in combination with chemotherapy, and those also have some information that have been reported as well. Dr. Rafeh Naqash: From a drug development standpoint, as you mentioned, there's always a tendency to combine something with something else. And in my practice, and I'm sure in your practice too, when we do early phase trials, many trials are still focused on choosing the maximum tolerated dose, which may be something that we need to gradually move away from as we try to implement these combinations of multiple antibodies plus some of these target agents from maybe the biological optimal dose rather than the maximal tolerant dose is a better way to look at the drugs, the pharmacokinetic profile, and then see what is likely the safest combination with the most appropriate target engagement. Do you have any thoughts on that or insights on that from a drug development perspective? Dr. Hatim Husain: It's a wonderful question and I think it is a very insightful question and understanding of where we are in space right now. And I agree with you that historically, cancer drug development was really hinged upon medicines that perhaps required higher doses to see a benefit or to inch out kind of marginal increases upon where we were at. Now, in combination with medicines that have non-overlapping mechanisms of action, the concept is: Can there actually be more synergy across an approach using combinatorial strategies rather than just additive effects? And I think that in some cases this is being studied with immune therapy, in some cases actually even in the context of other novel mechanisms for cancer therapy. I think that in my practice, I will really try to see how a patient at an approved dose will respond. But definitely I'm open to the concept that there may be a dose that doesn't have to be the maximally tolerated dose, but rather the dose that responses can be seen and perhaps actually at a lower dose than what drives many toxicities. Dr. Rafeh Naqash: I often describe this to my patients as individual patient dose optimization outside of a clinical trial, where I'm sure you've probably done this, where in older adults maybe a lower dose of osimertinib is tolerated better, or a lower dose of sotorasib or adagrasib for that matter, tolerated better with perhaps a similar level of efficacy, since we don't have comparisons between doses and efficacy so far.  So I think in the bigger picture, as we discussed in a nutshell, what I would really like the listeners to understand is as we try to move towards this field of precision medicine targeting more and more of the undruggable genes, there's bound to be a certain level of toxicity patterns that we'll start observing. So I think these real world scenarios which may not be addressed using clinical trials because it is in the real world setting where you cycle one treatment after another after another, which may or may not be allowed in most trials and the real world setting can inform, in certain cases, subsequent trial designs. So I think the most important message, at least that I took from your manuscript, was that these real world observations can make a huge difference and inform practice, even though the data sets may be small. Of course, you want to validate some of these findings in a bigger, broader setting, but proof of concept is there. And I think next time I see an individual in my clinic where I see better toxicity, I'll definitely try to talk to them about subsequent treatment with another KRAS inhibitor, maybe adagrasib or something else, if and when appropriate.  Do you have any closing thoughts on some of these things that we discussed? Dr. Hatim Husain: I just want to leave the audience actually with this concept that sometimes we group targeted therapy side effects as being class effects unanimously. And I do think actually that each inhibitor may have different off target effects on where medicine may act. We don't truly understand the mechanism of hepatotoxicity in the context of selective KRAS-G12C inhibitors. One of the hypotheses may be due to off target cysteine reactivity in the numerous off target binding sites that certain medicines may have over others. And just even qualitatively which off target binding sites there may be, and how that may lead to either immunogenic responses and other organs or such. So I do think that we do need more research to understand the mechanism. But I think where we are at right now in this space is not assuming that all medicines are going to have the exact same toxicity. I think especially when patients may not have other options, this is something to consider as well. Dr. Rafeh Naqash: Thank you so much. Now, outside of the scientific insights, Hatim, I know you a little bit from before. And knowing the kind of work that you've done in precision medicine, I'm really interested to know about where you started, how you started, how things have been, and what kind of advice you have for junior faculty fellows who are interested in this field of precision medicine that is becoming more and more exciting as we progress in the oncology space. Dr. Hatim Husain: Thank you, Rafeh. I will say, actually as a medical student, I was actually very interested in oncology, partly because it was then and still remains one disease or a constellation of diseases that just has such a high psychological burden on patients. And through the experiences I've had, I really can understand and relate with that concept. I did my medical school at Northwestern, residency at the University of Southern California, and then my oncology fellowship at Johns Hopkins University.  And now I've been on faculty at University of California, San Diego, for about 12 years now. It's been a great experience paralleled with the fact that during these last 12 years, I've really seen how the developments in precision oncology, both targeted therapy as well as immune therapy, have really blossomed and unfolded. A large area of my research in my career has kind of focused on cancer genome and integration of novel technologies to really see how they may have clinical application. When I was in my fellowship and as a young faculty, the liquid biopsy was actually coming into development. And this was hinged upon information that had come forward in the prenatal space where some patients actually who were undergoing prenatal testing during pregnancy were found to have complex karyotypes and genomic alterations and then retrospectively found to have cancer.  And doing my fellowship at Johns Hopkins, some of the pioneers in liquid biopsy were my mentors and really kind of instilled in me that passion for really thinking through how cancer genomics can be integrated through time. And some of the research that I have been doing has been looking at clonal evolution of cancer, how cancer is changing over time, and how we can think through the right surveillance strategies to really understand how that change is occurring. The dynamics of ctDNA in retrospective cohorts have been studied and shown that, you know, there can be associations between progression-free survival and other clinical endpoints. The current paper that we are speaking about parallels that in a certain way where, rather than say, looking at clonal evolution and say, the efficacy answer of sotorasib first and then adagrasib and how frequently can adagrasib salvage patients, this looks at it from a different angle around toxicity. And I think that is a key point because, at my core, I really do enjoy the clinical aspect of complex decision making on behalf of patients weighing efficacy and toxicity that they may have as they try to get the best quality of life through this journey. Dr. Rafeh Naqash: Thank you again, Hatim, for all those insights, both from the scientific perspective as well as personal perspective. We appreciate that you chose JCOPO as the destination for your work.  And thank you for listening to JCO Precision Oncology Conversations. Don't forget to give us a rating or review and be sure to subscribe so you never miss an episode. You can find all ASCO shows at asco.org/podcasts.   The purpose of this podcast is to educate and to inform. This is not a substitute for professional medical care and is not intended for use in the diagnosis or treatment of individual conditions.  Guests on this podcast express their own opinions, experience, and conclusions. Guest statements on the podcast do not express the opinions of ASCO. The mention of any product, service, organization, activity, or therapy should not be construed as an ASCO endorsement. Dr. Hatem Husain Disclosures Consulting or Advisory Role: AstraZeneca, Foundation Medicine, Janssen, NeoGenomics Laboratories, Mirati Speakers' Bureau: AstraZeneca, Janssen Institution Research Funding: Pfizer, Bristol-Myers Squibb, Regeneron, Lilly Travel, Accommodations, Expenses: AstraZeneca, Janssen, Foundation Medicine  

TILBAKEMELDING: Fremdeles følelser for franskmann med kjæreste? / PROBLEMER: Nysgjerrig på fengselsfuglen / Hvor lenge kan kjæresten være på besøk? / Bling, bling for dyr bling / Jeg vil ikke at drømmen skal ebbe ut / Mentalt utslitt av svigers / Forholdsklaustrofobi / Venn som strever / Vente på å bli frisk-perioden / Hva gjør jeg med gaver jeg ikke vil ha? Hør alle episodene i appen NRK Radio

Welcome, welcome, welcome to the Distraction Pieces Podcast with Scroobius Pip!This week Pip is joined by the first South Aisan stuntwoman in Europe, AYESHA HUSSAIN!It doesn't hurt to start with a legit history making credential, but let's not limit Ayesha's work to simply that... This chat is one that locks in so much of what has been bubbling in previous more movie-centric episodes with a hugely refreshing positive outlook on the future of the big and small screen. Ayesha's story is all here for you to engage with, and hopefully will throw up some truly inspirational portals for those looking to join in the world of stuntwork and acting. You'll hear a super wide range of goodness in here including the lessons she learned from her mother and the forever legacy which lives on in her absence, where rage and joy meet, rebellion, the Babes With Blades collective, navigating immigrant mentality and working in concert with that, her own work attitude, journeying through burlesque and cowboy culture, and - as stated in the introduction - being the first South Asian stuntwoman. You know this is a big episode. Dive in immediately.PIP'S PATREON PAGE if you're of a supporting natureIMDBBABES WITH BLADESJADE ANG JACKMANBABES WITH BLADES ARTICLELAUREN OKADIGBOSPEECH DEVELOPMENT WEBSTOREPIP TWITCH • (music stuff)PIP INSTAGRAMPIP TWITTERPIP PATREONPIP IMDBPOD BIBLE Hosted on Acast. See acast.com/privacy for more information.

3 big ideas discussed in this episode: BIG IDEA #1: Get great at identifying when you might be stuck BIG IDEA #2: Uncover blind spots through targeted questions BIG IDEA #3: Define and commit fully to your purpose and values Get the show notes for this episode here: https://AskJeremyJones.com/podcast

When resources are limited, how do you still access the best?Afeef Hussain wanted his team - and his country Maldives - to learn from the world's top minds. But bringing in world-class speakers and trainers isn't cheap.So instead of saying, "We can't afford them," he asked, "How can we make it work?"His solution? Leverage what he had.He invited top experts - leaders like Stephen M.R. Covey and other global thought leaders - to experience the Maldives, offering them world-class hospitality at Lux Resorts. In return, they shared their knowledge, mentoring his team and raising the leadership standards of an entire nation.Resourcefulness beats resources.Today, the Maldives isn't just a paradise for tourists - it's known as a place where top talent comes to learn, grow, and further their careers.We talked about this mindset - and much more - on the latest episode.Episode Shownoteshttps://howtolive.life/episode/087-wisdom-from-the-maldives-with-Afeef-HussainNext Wave6 month program for high performers hitting 40s and beyond to design the next phase of life. Register interest below - https://www.sharadlal.net/nextwave Leave us a messagehttps://howtolive.life/contactAbout Sharad Lalhttps://www.sharadlal.net/Follow usLinkedin: https://www.linkedin.com/in/sharadlal24/Facebook: https://www.facebook.com/PodcastHowtolive/Instagram: https://www.instagram.com/podcasthowtolive/

Ever feel like you're juggling a million things? This week, I'm chatting with Adeela Hussain Johnson, CEO of Beis Travel, about literally navigating chaos - from recent wildfires to the daily hustle of a mom and entrepreneur! We talk community, building a brand with heart, and why empathy is key. Adeela opens up about her journey as a South Asian woman in business, from the challenges of work-life balance to building a brand that truly cares. It's a conversation about resilience, empathy, and the power of community. Tune in for a dose of inspiration and maybe a few laughs!Also, friends, don't forget to check out Béis Travel for all of your luggage needs! Join Dr. Flora every Wednesday with tips to feel unstuck from your rut. Follow @the.beyondpodcast and @drflorasinha on Instagram to stay up to date!

Josh Sebo (COO of OfferVault), Adam Young (CEO of Ringba), industry legend Harrison Gevirtz and special guest Samar Hussain (CEO of Ecomm Producers) discuss: - Samar's journey from Call Centers to dominating the South Florida Insurance scene. - How is AI Transforming Call Centers? - Cultivating Trust - ColombiaCon2 - Resolving Conflicts through True Leadership - The Art of Balancing Personal and Professional Relationships Follow Us: OfferVault: WEBSITE: https://www.offervault.com/ FACEBOOK: https://www.facebook.com/offervault INSTAGRAM: https://www.instagram.com/offervaultmarketing/ TWITTER: https://www.twitter.com/offervault LINKEDIN: https://www.linkedin.com/company/offer-vault/ Adam Young: RINGBA: https://www.ringba.com RINGBA's INNER CIRCLE: https://try.ringba.com/inner-circle/ FACEBOOK: https://www.facebook.com/ringba INSTAGRAM: https://www.instagram.com/adamyoung/ TWITTER: https://www.twitter.com/arbitrage LINKEDIN: https://www.linkedin.com/in/capitalist Harrison Gevirtz: INSTAGRAM: https://www.instagram.com/affiliate/ LINKEDIN: https://www.linkedin.com/in/harrisongevirtz/ Samar Hussain: ECOMM PRODUCERS: https://ecommproducers.com/ INSTAGRAM: https://www.instagram.com/insta_samar/ LINKEDIN: https://www.linkedin.com/in/samar-hussain-6623b978/

230: In this episode, Afshan Hussain, founder of PregnancySafeCosmetics, dives into how environmental toxins are affecting fertility and what you can do to optimize your chances of conception. Afshan's company partners with over 20 fertility clinics across the U.S. to offer a fertility program focused on toxin reduction in five key areas: food and water, beauty and personal care, clothing, household supplies, and the home & office environment. We discuss the rising fertility crisis, how toxins are stored in fat cells, and the importance of clean beauty. If you're trying to conceive or just want to live a healthier, toxin-free life, this episode is packed with practical tips for reducing your toxic burden and improving your fertility. Key Points: How environmental toxins impact fertility and overall health Practical steps to detox your environment and reduce toxic exposure The importance of clean beauty and safe skincare products for fertility The role of toxins in both female and male fertility, including declining sperm count Use code REALFOOD10 Shop Fertility and Pregnancy Safe skin care at: https://www.pregnancysafecosmetics.com/shop Sponsored By: LMNT Get your free Sample Pack with any LMNT drink mix purchase at drinklmnt.com/realfoodology Birch Go to Birchliving.com/realfoodology for 20% Off Sitewide + 2 Free Eco-Rest Pillows with Mattress Purchase.  BIOptimizers  Order now at bioptimizers.com/realfoodology and use code realfoodology for 10% off any order.  Paleovalley Save at 15% at paleovalley.com/realfoodology and use code REALFOODOLOGY Timestamps:  00:00:00 - Introduction 00:06:16 - The fertility crisis 00:08:28 - Fertility after 40 vs. before 00:12:27 - Pregnancy detox & “clean beauty” 00:16:45 - How environmental toxins impact fertility 00:19:48 - The alarming decline in sperm count 00:21:56 - Most common toxins to be aware of 00:23:38 - Understanding toxic burden 00:25:30 - Why awareness of toxins isn't negative 00:30:26 - Skincare regulation: U.S. vs. EU 00:35:08 - Ecocert verification and the importance of natural ingredients 00:40:10 - Toxins are stored in our fat cells 00:45:39 - Tips for living toxin-free 00:51:11 - Lifestyle changes and product recommendations 00:58:04 - Choosing safe bath and beauty products 01:03:01 - Real-life testimonials and success stories 01:08:50 - Fertility testing 01:12:15 - Afshan's personal health non-negotiables Check Out  Website Instagram  X (Twitter) Check Out Country:  LEAVE US A VOICE MESSAGE Check Out My new FREE Grocery Guide! @realfoodology @realfoodologypodcast www.realfoodology.com My Immune Supplement by 2x4 Air Dr Air Purifier AquaTru Water Filter EWG Tap Water Database  Produced By: Drake Peterson

Alderman Ray Lopez and Mayor Johnson have different attitudes about Trump's plan to round up immigrants—that's for sure. Ben riffs. Rummana Hussain talks brainwashing. How Trump has successfully turned Americans, some recent immigrants included, against immigrants. Also, updates on the ADL and Musk and the Cultural Center anti-war puppets. Talk about cancel culture. Rummana is a columnist and editorial writer for the Sun-Times. Her views are her own.See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

Welcome back, beautiful souls! In this empowering episode, I welcome Afshan Hussain, the visionary founder of Pregnancy Safe Cosmetics. Together, we unravel the hidden dangers of toxins and their profound effects on fertility and overall health.   Afshan shares her groundbreaking work in creating safer, toxin-free products and offers practical advice on how to reduce exposure to harmful substances in our daily lives.   Afshan's insights into clean beauty, organic food, and filtered water provide listeners with actionable steps to foster healthier environments for themselves and their families.   This episode is a call to action for embracing toxin-free living and supporting fertility through conscious lifestyle choices.     About Afshan:   Afshan Hussain is the founder of PregnancySafeCosmetics, a company that works with fertility clinics & coaches across the United States to help patients maximize their chances of getting pregnant. The company's fertility program is featured in over 20 clinics in the US, including CNY Fertility's 13 clinics and monitoring locations. The program uses an integrative health approach to toxin reduction in each of the following five areas: Food and water; Beauty and personal care products; Clothing; Household cleaning supplies; Contact items and home & office environment.     Ps: If you are ready to finally see how you can bring in thousands of dollars per week while just doing a few simple actions (and never feel like you *HAVE* to work an 8 hour day again)? To have clear direction in your day to day activities so you can easily implement strategies for more simplicity in your life and biz? Then 5 weeks to 5 figures course is for you! Check the link below

Welcome to Khandaan: A Bollywood Podcast where this week we're talking Classic Bollywood with CARAVAN (1971). Directed by Nasir Hussain and produced by Tahir Hussain (Aamir's dad), Caravan is a typically enjoyable proto-Bollywood adventure romp from the House of Hussain. Starring Asha Parekh, Aruna Irani, Helen, and Jeetendra among others, this movie is especially notable for its outstanding RD Burman soundtrack. We also discuss a couple of other recent Bollywood movies and their trailers / songs like BADASS RAVIKUMAR, LOVEYAPA, Bhassad Macha and BLACK WARRANT as well as Pakistan's first full length animated movie The Glassworker.

Welcome to one of the most heated exchanges of views in the history of the Holy Smoke podcast. In this episode, Damian Thompson talks to the distinguished Islamic scholar Dr Musharraf Hussain about the controversy surrounding the Muslim background of some of the accused in the crimes of Britain's 'grooming gangs'.  Damian draws an analogy between the Catholic hierarchy's cover-up of sex abuse by priests, and what he claims was the role of certain local Muslim community leaders in restricting debate about, and investigation of, abuse committed by men from Pakistani families. To say that there was no common ground between Dr Thompson and Dr Hussain would be putting it mildly, alas... Produced by Patrick Gibbons.

Welcome to one of the most heated exchanges of views in the history of the Holy Smoke podcast. In this episode, Damian Thompson talks to the distinguished Islamic scholar Dr Musharraf Hussain about the controversy surrounding the Muslim background of some of the accused in the crimes of Britain's 'grooming gangs'.  Damian draws an analogy between the Catholic hierarchy's cover-up of sex abuse by priests, and what he claims was the role of certain local Muslim community leaders in restricting debate about, and investigation of, abuse committed by men from Pakistani families. To say that there was no common ground between Dr Thompson and Dr Hussain would be putting it mildly, alas... Produced by Patrick Gibbons.

Rummana Hussain asks and answers the difficult question. Why is it that so many people find it difficult to feel or express empathy for others in dire need? At least in relation to the fires in LA. Also, a few words about the oligarchs who have signed up with MAGA. And a defense of Suze Rotolo--who has been reduced to a weepy-eyed wimp in the Bob Dylan movie. Uh-oh, look out QT. Rummana is an editorial writer and columnist for the Chicago Sun-Times. Her views are her own.See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

This week, Dr. Joy Hussain shares new insights from her sauna therapy research and its transformative potential for health. Think of heat/cold exposure as training on par with exercise or brain training. Learn how sweating impacts metabolic health, the connection between hormones and thermoregulation, and how sauna use could alleviate menopause symptoms. Dr. Hussain discusses gender differences in heat tolerance, emerging research on sweat composition, and practical ways to enhance resilience to stress. This episode challenges long-held beliefs about sweating and offers actionable tips to integrate thermal therapy into daily life.How Long Will You Live? Take our quiz today and find out! Visit: ageist.com/longevity-quizThanks To Our SponsorsTimeline Nutrition — our number one supplement for cell support and mitochondrial function. Listeners receive 10% off your first order of Mitopure with code AGEIST at TimelineNutrition.com/ageist. Our Place – our top cookware brand for non-toxic, PFA-free pots and brands. Use code “AGEIST” for 10% off at fromourplace.com LMNT Electrolytes — our favorite electrolytes for optimal hydration. Listeners receive a free 8-serving sample pack with their purchase at DrinkLMNT.com/AGEIST. Key Quotes“The act of sweating and its content is unexpectedly rich in metabolic information—we've only scratched the surface of its potential.”“Regular sauna use could help menopausal women better manage hot flashes by training the thermoregulatory system.”“Stress reduction was the number one motivation for sauna use globally—it's a remarkable tool for mental and physical resilience.”Connect with Our GuestWebsite: https://healthwithjoy.com.au/aboutDr. Joy's researchFull Interview TranscriptConnect with AGEISTNewsletterInstagramWebsiteSay hi to the AGEIST team!